The Drug Eluting Stents Center

Filter Your Results




BD Issues Statement in Response to FDA’s Letter Announcing Long-Term Data Review of Paclitaxel Devices Used in PAD

March 22, 2019 -- BD (Becton, Dickinson and Company) has issued a statement regarding the recent FDA letter that announced the preliminary review of long-term data on the use …

Highlights From the VIVA Vascular Leaders Forum on Paclitaxel Safety

March 2019—Points of consensus, contention, and paths forward.

FDA to Convene Advisory Committee Meeting After Preliminary Review Finds Signal of Increased Mortality With Paclitaxel-Eluting Devices

March 15, 2019 -- The FDA has announced that its preliminary review of the long-term follow-up data on paclitaxel-coated balloons and paclitaxel-eluting stents to treat periph…

No Long-Term Increased Mortality Seen in Medicare PAD Patients Treated With Peripheral DES

March 14, 2019 -- Findings from an investigation examining long-term mortality between drug-eluting stent (DES) and bare-metal stent (BMS) implantation in patients with a prin…

Medtronic Publishes Correction Letter and Revised Analysis of IN.PACT Global Postmarket Study in JACC

March 7, 2019 -- Medtronic announced the publication of a correction letter by Peter A. Schneider, MD, et al online ahead of print in Journal of the American College of Cardio…

SVS Establishes Task Force on Paclitaxel Safety

March 6, 2019 -- The Society for Vascular Surgery (SVS) announced the creation of a Task Force on Paclitaxel Safety to evaluate all available data related to paclitaxel use in…

Pooled Analysis of Four Trials Shows No Increase in 2-Year Mortality With Paclitaxel-Coated Balloons

March 6, 2019 -- Thomas Albrecht, MD, et al conducted a patient-level pooled analysis of four multicenter, randomized controlled trials (RCTs) to determine the 2-year mortalit…

On the Paclitaxel Meta-Analysis: A Conversation With Konstantinos Katsanos, MD

March 2019—Dr. Katsanos discusses the methods and findings of his group’s meta-analysis, the patient-level data presented in response, and potential next steps.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.